Genetic Technologies Limited
GENE
$0.765
-$0.015-1.92%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.21% | 12.00% | 0.48% | -0.03% | 2.27% |
| Total Depreciation and Amortization | 0.24% | -8.63% | -0.44% | -20.57% | -2.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.20% | -128.43% | -0.47% | -24.22% | -2.27% |
| Change in Net Operating Assets | 0.22% | -- | -- | -- | 2.28% |
| Cash from Operations | -0.20% | -42.55% | 0.47% | -9.50% | 2.27% |
| Capital Expenditure | 0.00% | 82.61% | 0.00% | -91.67% | 2.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.03% | -74.81% | -0.52% | 3.48% | -2.35% |
| Cash from Investing | 0.00% | -72.01% | -0.68% | -9.51% | -2.40% |
| Total Debt Issued | 0.00% | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -1.85% | 0.00% | -1.65% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -109.09% | 0.00% | 99.76% | 0.00% |
| Cash from Financing | 0.20% | 1,826.09% | 0.35% | -102.82% | -2.26% |
| Foreign Exchange rate Adjustments | -0.48% | -154.88% | 0.00% | -111.52% | -2.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.21% | 33.70% | 0.47% | -244.00% | -2.26% |
